Patent · US Active

Medicament

US10966912B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

SYMRISE AG · DE

Inventors

Marielle Le Maire · Boulogne-Billancourt, FR
Imke Meyer · Bodenwerder, DE
William Johncock · Reinbek, DE

Key dates

Filing date	Mar 21, 2016
Grant date	Apr 6, 2021
Priority date	—
Expiry date	Mar 21, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q19/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention belongs to the fields of pharmaceuticals and cosmetics, and concerns on the one hand a medicament for the inhibition of and refers also on the cosmetic, non-therapeutic use for the treatment of hyperpigmentation, particularly induced by sun light radiation, preferably induced by visible light radiation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.